Literature DB >> 2949899

Suppression of Staphylococcus aureus Cowan I-induced immunoglobulin synthesis in vitro: discrimination between the presence of suppressor T cell precursors and effectors.

J Pryjma, A Pituch-Noworolska, H D Flad, A J Ulmer, M Ernst.   

Abstract

In co-cultures with control cells lymphocytes obtained from some patients with hypogammaglobulinaemia can suppress PWM but not S. aureus Cowan I-induced polyclonal immunoglobulin production. When such co-cultures were stimulated at the same time with both mitogens, the response was greatly suppressed. This phenomenon was further studied in cultures of lymphocyte populations isolated from healthy donors. It was found that suppressor T lymphocytes activated by PWM in cultures co-stimulated with Con A, with high T:B cell ratio, or with an increased proportion of OKT8+ T cells can suppress the S. aureus-induced response. In contrast, under the same conditions S. aureus did not activate suppressor cells. Moreover, in cultures stimulated with this polyclonal B-cell activator OKT8+ lymphocytes could serve as helper cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2949899      PMCID: PMC1542530     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  Human B-cell activation in vitro. T cell-dependent pokeweed mitogen-induced differentiation of blood B lymphocytes.

Authors:  F Gmelig-Meyling; A G UytdeHaag; R E Ballieux
Journal:  Cell Immunol       Date:  1977-09       Impact factor: 4.868

2.  Activation of human B lymphocytes. III. Concanavalin A-induced generation of suppressor cells of the plaque-forming cell response of normal human B lymphocytes.

Authors:  B F Haynes; A S Fauci
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

3.  Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia.

Authors:  T A Waldmann; M Durm; S Broder; M Blackman; R M Blaese; W Strober
Journal:  Lancet       Date:  1974-09-14       Impact factor: 79.321

4.  Staphylococcal protein A, a T cell-regulated polyclonal activator of human B cells.

Authors:  P E Lipsky
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

5.  Induction and suppression of immunoglobulin synthesis in cultures of human lymphocytes: effects of pokeweed mitogen and Staphylococcus aureus Cowan I.

Authors:  J Pryjma; J Muñoz; R M Galbraith; H H Fudenberg; G Virella
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

6.  Suppression of B-cell differentiation by leukocytes from hypogammaglobulinemic patients.

Authors:  F P Siegal; M Siegal; R A Good
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

7.  Use of a human plaque-forming cell assay to study peripheral blood bursa-equivalent cell activation and excessive suppressor cell activity in humoral immunodeficiency.

Authors:  H G Herrod; R H Buckley
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

8.  The use of Staphylococcus aureus Cowan I for evaluation of suppressor-T-cell activity in hypogammaglobulinemia: evidence for two functionally distinct suppressor T cells.

Authors:  J Pryjma; A Pituch-Noworolska; E Bernatowska
Journal:  Clin Immunol Immunopathol       Date:  1984-12

9.  Monocyte dependence of pokeweed mitogen-induced differentiation of immunoglobulin-secreting cells from human peripheral blood mononuclear cells.

Authors:  S A Rosenberg; P E Lipsky
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

10.  Abnormal B cell differentiation and variable increased T cell suppression in immunodeficiency with hyper-IgM.

Authors:  H J Krantman; E R Stiehm; R H Stevens; A Saxon; R C Seeger
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

View more
  1 in total

1.  Analysis of impaired in vitro immunoglobulin synthesis in rheumatoid arthritis.

Authors:  I Jokinen; K Poikonen; T Möttönen; P Hannonen; M Oka; J Ilonen; H M Surcel; R Karttunen; H Arvilommi
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.